RxDoctor Payments DataLook up a doctor →

Linda Harper

Psychiatry · Orlando, FLNPI 1114259223

Payments from drug & device makers

$8,529,250in general payments, 2019–2025

Across 871 payments — averaging $9792.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sage Therapeutics, LLC$2.5M
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$1.7M
  • Supernus Pharmaceuticals, Inc.$1.2M
  • Romark Laboratories, LC$834K
  • Pfizer$426K
  • Acadia Pharmaceuticals Inc$394K
  • plus $1.4M from 14 others
$73,919in research payments, 2019–2025

Across 39 payments — averaging $1895.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Arbor Pharmaceuticals, Inc.$68K
  • Supernus Pharmaceuticals, Inc.$2K
  • Acadia Pharmaceuticals Inc$2K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$2K
  • Eli Lilly$150

General payments by program year

19
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,529,250 in reported general payments places this provider in the 95th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida

Other psychiatry in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →